Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Polyzos, S. A., Kita M., Efstathiadou Z., Goulis D. G., Benos A., Flaris N., et al. (2009).  The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules.. Exp Clin Endocrinol Diabetes. 117(4), 159-64.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Polyzos, S. A., Kountouras J., Tsatsoulis A., Zafeiriadou E., Katsiki E., Patsiaoura K., et al. (2013).  Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease.. Hormones (Athens). 12(3), 405-16.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.
Polyzos, S. A., Kita M., Goulis D. G., Benos A., Flaris N., Leontsini M., et al. (2008).  Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004).. Exp Clin Endocrinol Diabetes. 116(8), 496-500.
Polyzos, S. A., Goulis D. G., Kountouras J., Mintziori G., Chatzis P., Papadakis E., et al. (2014).  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.. Hormones (Athens). 13(4), 519-31.
Polyzos, S. A., Kountouras J., Slavakis A., Zafeiriadou E., Patsiaoura K., Katsiki E., et al. (2013).  A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study.. Biomarkers. 18(7), 607-13.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z., Kita M., Litsas I., Avramidis A., et al. (2009).  The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.. Horm Metab Res. 41(11), 846-50.
Polyzos, S. A., & Anastasilakis A. D. (2009).  Clinical complications following thyroid fine-needle biopsy: a systematic review.. Clin Endocrinol (Oxf). 71(2), 157-65.
Polyzos, S. A., Kountouras J., Zavos C., & Stergiopoulos C. (2010).  Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.. Med Hypotheses. 74(6), 1089-90.
Polyzos, S. A., Anastasilakis A. D., & Arsos G. (2012).  Acute transient thyroid swelling following needle biopsy: an update.. Hormones (Athens). 11(2), 147-50.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact.. Saudi J Gastroenterol. 17(6), 425-6.
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Polyzos, S. A., Kountouras J., Papatheodorou A., Patsiaoura K., Katsiki E., Zafeiriadou E., et al. (2013).  Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.. Metabolism. 62(1), 121-6.
Polyzos, S. A., & Terpos E. (2016).  Clinical vertebral fractures following denosumab discontinuation.. Endocrine. 54(1), 271-272.
Polyzos, S. A. (2011).  Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.. Clin Rheumatol. 30(1), 149-50.
Polyzos, S. A., Chrysavgis L., Vachliotis I. D., Chartampilas E., & Cholongitas E. (2023).  Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy.. Semin Cancer Biol. 93, 20-35.
Polyzos, S. A., Kountouras J., & Tsoukas M. A. (2015).  Circulating homocysteine in nonalcoholic fatty liver disease.. Eur J Intern Med. 26(2), 152-3.
Polyzos, S. A., Kountouras J., Patsiaoura K., Katsiki E., Zafeiriadou E., Deretzi G., et al. (2012).  Serum homocysteine levels in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 11(1), 68-76.
Polyzos, S. A., & Mantzoros C. S. (2019).  Obesity: seize the day, fight the fat.. Metabolism. 92, 1-5.
Polyzos, S. A., & Mantzoros C. S. (2017).  Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.. Metabolism. 72, A4-A10.
Polyzos, S. A., Kountouras J., Zavos C., Pyrrou N., & Tantsi N. (2013).  Helicobacter pylori infection and serum adiponectin.. Helicobacter. 18(4), 321-2.
Polyzos, S. A., Kountouras J., Anastasiadis S., Doulberis M., & Katsinelos P. (2018).  Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?. Hepatology. 68(1), 389.
Polyzos, S. A., Anastasilakis A. D., Litsas I., Sapranidis M., Efstathiadou Z., Kita M., et al. (2010).  Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.. J Clin Densitom. 13(2), 190-6.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2012).  Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.. J Clin Gastroenterol. 46(4), 272-84.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές